Stock UniverseDerived research view · source repositories remain read-only

Climb Bio, Inc. (CLYM)

Therapeutics / Biopharma · Healthcare / Biotechnology
Score Band
Speculative
Selection Score
29.82
Global Rank
2038
Market Cap
341.37M
Latest Close
10.55
RS Composite
152.25% · G#16

Price Movement

3Y daily adjusted close
Loading price data...
Adjusted close SMA60D
1M
-13.67%
3M
46.94%
6M
506.32%
1Y
717.83%
3Y
261.30%
5Y
-33.65%
10Y
-33.65%

Volume

Loading volume data...
Volume Volume MA20D

Latest volume: 985.56K · 30-day average: 1.00M · Max drawdown over stored range: -96.05%

Research Snapshot

Relative Strength vs SPX

RS Composite152.25%
20D RS-12.05%
60D RS34.96%
120D RS351.70%
Global RS Rank16 · 99.52% percentile
Watch+Speculative RS Rank7 · 99.67% percentile
Group ScopeWatch+Speculative
Primary RS Rank2 · 99.56% percentile
Snapshot Date2026-06-05

RS uses adjusted close where available. Global RS Rank is recalculated from the current non-low pool. Group RS Rank is recalculated inside the company’s own actionable band group.

Research Links

StockAnalysis
Yahoo Finance
Perplexity Finance
Finviz
Seeking Alpha
WhaleWisdom
FinanceCharts
SEC EDGAR Search
SEC Company Search

Official company website and investor-relations URLs are not inferred unless a reliable dynamic source is added.

Classification

Primary Rank310 / 701
Primary Percentile55.92
Score Notesmarket-cap support, industry-tailwind, small-cap penalty

Gemini Deep Research

Loading Gemini reports...

Manual Estimates

Loading manual estimates...

Forward Valuation

Loading forward valuation...

SEC TTM Fundamentals

No processed TTM rows for CLYM.

TTM Valuation

No SEC TTM valuation available.

Financial Statement Metrics

MetricFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025
Revenue
Revenue Growth (YoY)
Gross Profit
Operating Income-11.767-35.672-45.135-21.466-27.003
Free Cash Flow-36.072-37.369-20.599-15.562-54.542
Free Cash Flow Per Share-2.942118996120158-1.4202505864913946-0.762513-0.32310908257720955-0.8043102013658467
EPS (Diluted) GAAP-10.491298-4.243528-1.72-1.301324-1.5343
EPS Growth
EPS Non-GAAP
Gross Margin
Operating Margin
Profit Margin
Free Cash Flow Margin
Shares Outstanding (Diluted)2.187812.260626.311626.987148.163367.8121
Shares Change (YoY)31.718%460.402%114.603%2.568%78.468%40.796%

SEC Quarterly Fundamentals

No processed quarterly rows for CLYM.